<DOC>
	<DOCNO>NCT02405182</DOCNO>
	<brief_summary>Amyotrophic lateral sclerosis ( ALS ) disable rapidly progressive neurodegenerative disorder . There treatment significantly slow progression . Increasing age important risk factor develop ALS ; thus , societal impact devastate disease become profound population age . A significant hurdle find effective treatment inability accurately measure brain degeneration human . Advanced magnetic resonance imaging ( MRI ) techniques hold promise respect , may assist aid diagnosis efficient test new drug . Different MRI feature brain degeneration measure large sample patient ALS . The study operate within Canadian ALS Neuroimaging Consortium ( CALSNIC ) . CALSNIC clinical research platform comprise ALS clinic standardize clinical neuroimaging protocol .</brief_summary>
	<brief_title>MRI Biomarkers ALS</brief_title>
	<detailed_description>This study use advance Magnetic Resonance Imaging ( MRI ) techniques measure brain change ALS relate neurological condition . Results cognitive neurological test compare MRI . It believe technique reveal change brain help u understand normal brain function symptom neurological disease see ALS , well provide objective measurement degeneration ( call biomarker ) . This could improve process new drug treatment neurological disease evaluate , also health care professional address needs patient disease . Furthermore , biomarker may give insight biological factor related diverse variable clinical feature amongst different patient . Subjects recruit ALS clinic part Canadian ALS Neuroimaging Consortium ( CALSNIC ) . Patients diagnosis ALS , PLS , PMA , FTD . Healthy control age gender match patient . Subjects visit respective site undergo clinical evaluation MRI . Follow visit occur approximately 3-6 month interval . Most subject 2 follow visit ; visit may occur subject physically able continue protocol .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Patients adults diagnosis motor neuron disease ( MND ) , include ALS , PLS , PMA , well frontotemporal dementia ( FTD ) without motor neuron sign . Healthy control age 40 also recruit age gendermatched patient . Subjects psychiatric/CNS illness Major Depressive Disorder , Schizophrenia , Bipolar disorder , significant head injury . Subjects ineligible MRI investigation due pacemaker metallic foreign body , significant claustrophobia could affect ability MRI scan . These exclusion criterion also apply control .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>MRI</keyword>
	<keyword>Biomarker</keyword>
</DOC>